Immediate Impact
32 standout
Citing Papers
Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
2023 Standout
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Standout
Works of Pietro Sozzi being referenced
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
2001
Infections in haematologic neoplasms: autopsy findings.
1991
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Pietro Sozzi | 37 | 4 | 2 | 17 | 14 | 4 | 52 | |
| Judy Hoffman-Bolton | 37 | 6 | 14 | 18 | 3 | 63 | ||
| Olivier Arsène | 33 | 3 | 14 | 4 | 7 | 53 | ||
| I Resnick | 15 | 3 | 21 | 5 | 3 | 55 | ||
| Harkarandeep Singh | 17 | 1 | 1 | 24 | 13 | 5 | 54 | |
| Max Cohen | 13 | 2 | 62 | 13 | 20 | 6 | 170 | |
| R. L. Hayes | 21 | 2 | 11 | 35 | 15 | 7 | 170 | |
| Alban Bessede | 40 | 1 | 4 | 20 | 6 | 6 | 55 | |
| Emily Howe | 11 | 2 | 22 | 13 | 5 | 38 | ||
| Irinel Parepa | 10 | 1 | 5 | 8 | 8 | 5 | 40 | |
| H. B. Bueno-de-Mesquita | 30 | 1 | 2 | 6 | 33 | 3 | 88 |
All Works
Loading papers...